Fulvestrant 129453-61-8

본문 바로가기


Home > Product > Fulvestrant 129453-61-8
Product
Fulvestrant 129453-61-8
Posting date : Apr 25, 2017
Membership
Free Member Scince Apr 25, 2017
FOB Price
Negotiable
Min. Order Quantity
10g
Supply Abillity
1000Kg/Month
Port
Negotiable
Payment Terms
T/T, Western Union, MoneyGram,Bitcoin
Package
As you request
Keyword :
Category
Contact
Mike
          0 likes     
Product Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
kafen
HS-CODE
-
Package & Delivery Lead Time
Package
As you request
Detailed Description
Treatment Receptor Metastatic Drug Fulvestrant / Faslodex 129453-61-8 Anti Cancer Steroids Raw Powder
Basic Info.
CAS:129453-61-8Purity:99%Appearance:white powderSynonyms: FASLODEXChemical Name:(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diolMolecular Fomular:C32H47F5O3SMolecular Weight:606.77Density:1.201 g/cm3Melting Point:104-106°CBoiling Point:674.8 °C at 760 mmHgPackage:10g/foil bagUsage:To treat estrogen receptor positive metastatic breast cancer in postmenopausal women, with disease progression following antiestrogen therapy.
Description: 
Fulvestrant also called Faslodex or AstraZeneca,is is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It works by blocking the actions of estrogen in the body. Fulvestrant is a complete estrogen receptor antagonist with no agonist effects, which in addition, accelerates the proteasomal degradation of the estrogen receptor. The drug has poor oral bioavailability, and is administered monthly via intramuscular injection.Certain types of breast cancer use estrogen to grow and multiply in the body.do not use fulvestrant if you are allergic to any ingredient in fulvestrant ,and Contact your doctor or health care provider right away if any of these apply to you.
Applications:
Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells. Fulvestrant stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cell has.
Fulvestrant Acetate (Faslodex, AstraZeneca) is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen receptor.
Fulvestrant Acetate is a selective estrogen receptor down-regulator (SERD). Fulvestrant is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. The dosing schedule for fulvestrant remains under investigation in an attempt to optimize its effectiveness.

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top